Recruiting Depression Studies in Watertown
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD....
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression....
About Depression Clinical Trials in Watertown
Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.
There are currently 2 depression clinical trials recruiting participants in Watertown, MA. These studies are seeking a combined 800 participants. Research is being sponsored by Neurocrine Biosciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Depression Clinical Trials in Watertown — FAQ
Are there depression clinical trials in Watertown?
Yes, there are 2 depression clinical trials currently recruiting in Watertown, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Watertown?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Watertown research site will contact you about next steps.
Are clinical trials in Watertown free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Watertown studies also compensate for your time and travel.
What depression treatments are being tested?
The 2 active trials in Watertown are testing new therapies including novel drugs, biologics, and treatment approaches for depression.
Data updated March 2, 2026 from ClinicalTrials.gov